Cigna Group (CI)

The Cigna Group's stock price has been impacted by several events in the past six months. On October 30, 2025, CI shares closed down more than 17% following its Q3 2025 earnings report due to investor concerns regarding changes to its pharmacy-benefit management (PBM) business model. Over the last 12 months, the stock's price has increased by 0.13%, with a year-to-date return of 1.48%. As of January 9, 2026, the share price was $278.95, representing a slight decline of 0.01% from January 10, 2025.

Demand for health insurance products and services exhibits seasonality, with a surge in customer demand during the annual open enrollment periods for health plans, typically from November to January. Healthcare spending also shows a predictable annual pattern, with relatively high spending in January, a drop in February, and a gradual increase month by month, becoming quite high by December, driven by the reset of insurance deductibles at the beginning of the year.

The Cigna Group is a multinational managed healthcare and insurance company providing healthcare solutions and services through Cigna Healthcare and Evernorth Health Services. Its offerings include health insurance (medical, dental, disability, life, and accident), healthcare services (behavioral health and wellness, vision, supplemental health solutions, and savings and spending accounts), pharmacy benefit management (PBM) through Evernorth Health Services, and care services and management solutions.

The Cigna Group has a significant global presence, serving over 178 million customer relationships in more than 30 countries and jurisdictions. Its headquarters are in Bloomfield, Connecticut, with global operations and sales offices across North America, Europe, Asia, and the Middle East.

The Cigna Group has received positive recognition for its corporate practices, ranking No. 7 on Fair360's 2024 Top 50 Companies list and being recognized by Forbes as the top company in the healthcare industry for its leadership in global sustainability. However, Cigna has also faced controversies, including engaging in automatic denials of insurance claims without reviewing them.

Institutional investors hold a substantial portion of The Cigna Group's stock, ranging from 87.04% to 89%. Major institutional shareholders include Vanguard Group Inc, BlackRock, Inc., State Street Corp, Price T Rowe Associates Inc /md/ (also T. Rowe Price Group, Inc.), Massachusetts Financial Services Co /ma/, Fmr Llc, Dodge & Cox, and Sanders Capital, LLC. Individual investors hold approximately 10% of the company, while Cigna Group insiders own under 1.65%. H. Edward Hanway is noted as a significant individual shareholder, owning 1.78 million shares.